Neuroimmune mechanisms of depression in heart failure

Methods in Molecular Biology

Volumn 934, Issue , 2012, Pages 165-182

  Jiménez, Jessica A ^a   Mills, Paul J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; Heart failure; Inflammation; Renin angiotensin aldosterone system; Sympathetic nervous system

Indexed keywords

CYTOKINE;

ANIMAL; ARTICLE; CELLULAR IMMUNITY; COMORBIDITY; DEPRESSION; HEART FAILURE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; PATHOPHYSIOLOGY; PSYCHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; COMORBIDITY; CYTOKINES; DEPRESSION; HEART FAILURE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; NEUROIMMUNOMODULATION; PSYCHONEUROIMMUNOLOGY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84868681734     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-071-7_9     Document Type: Article

References (48)

1. Kent LK, Shapiro PA (2009) Depression and related psychological factors in heart disease. Harv Rev Psychiatry 17:377-388
2. Norra C, Skobel EC, Arndt M et al (2008) High impact of depression in heart failure: early diagnosis and treatment options. Int J Cardiol 125:220-231
3. Watson K, Summer KM (2009) Depression in patients with heart failure: clinical implications and management. Pharmacotherapy 29: 49-63
4. Shapiro P (2009) Treatment of depression in patients with congestive heart failure. Heart Fail Rev 14:7-12
5. Williams SA, Kasl SV, Heiat A et al (2002) Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med 64:6-12
6. Abramson J, Berger A, Krumholz HM et al (2001) Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161:1725-1730
7. Bui AL, Horwich TB, Fonarow GC (2010) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30-41
8. Roger VL, Go AS, Lloyd-Jones DM et al (2010) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123:18-209
9. Levy D, Kenchaiah S, Larson MG et al (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347:1397-1402
10. DeFrances CJ et al (2008) 2006 National hospital discharge survey. Natl Health Stat Report 5:1-20
11. Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215
12. Hunt SA, Abraham WT, Chin MH et al (2009) 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53:e1-e90
13. Bristow MR (2000) ß-adrenergic receptor blockade in chronic heart failure. Circulation 101:558-569
14. Rutledge T, Reis VA, Linke SE et al (2006) Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48:1527-1537
15. Kessler RC, Berglund P, Demler O et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-3105
16. Gottlieb SS, Khatta M, Friedmann E et al (2004) The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43:1542-1549
17. Havranek EP, Spertus JA, Masoudi FA et al (2004) Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44:2333-2338
18. Tousoulis D, Antonopoulos AS, Antoniades C et al (2010) Role of depression in heart failure-choosing the right antidepressive treatment. Int J Cardiol 140:12-18
19. Sherwood A, Blumenthal JA, Trivedi R et al (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167:367-373
20. Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161:1849-1856
21. Jiang W, Kuchibhatla M, Clary GL et al (2007) Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 154:102-108
22. Vaccarino V, Kasl SV, Abramson J et al (2001) Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38:199-205
23. Frasure-Smith N, Lesperance F, Habra M et al (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrialfibrillation and heart failure. Circulation 120:134-140
24. Sherwood A, Blumenthal JA, Hinderliter AL et al (2011) Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol 57:418-423
25. Sullivan M, Levy WC, Russo JE et al (2004) Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail 10:390-396
26. Jiang W, Kuchibhatla M, Cuffe MS et al (2004) Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 110:3452-3456
27. Hallas CN, Wray J, Andreou P et al (2011) Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung 40:111-121
28. Gottlieb SS, Kop WJ, Ellis SJ et al (2009) Relation of depression to severity of illness in heart failure (from Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)). J Am Coll Cardiol 103:1285-1289
29. Maes M (2001) Psychological stress and the inflammatory response system. Clin Sci 101: 193-194
30. Penninx BW, Kritchevsky SB, Yaffe K et al (2003) Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 54:566-572
31. Bremmer MA, Beekman AT, Deeg DJ et al (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106:249-255
32. Beck A, Steer RA (1987) Manual for the revised Beck Depression Inventory. Psychological Corportation, San Antonio
33. Linke SE, Rutledge T, Johnson BD et al (2009) Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry 66:499-507
34. Wirtz PH, Hong S, Redwine LS et al (2009) Depressive symptoms are associated with soluble P-selectin reactivity to acute exercise in heart failure. Biol Psychiatry 65:801-807
35. Wirtz PH, Redwine LS, Mills PJ (2010) Response regarding inflammation as a predictor of depression in heart failure. Brain Behav Immun 24:174-175
36. Szabo MC, Butcher EC, McIntyre BW et al (1997) RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur J Immunol 27:1061-1068
37. Chen J, Fujimoto C, Vistica BP et al (2006) Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation. J Immunol 177:3362-3368
38. Adamopoulos S, Parissis J, Kroupis C et al (2001) Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22:791-797
39. Pyo RT, Sui J, Dhume A et al (2006) CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41:834-844
40. Frangogiannis NG, Dewald O, Xia Y et al (2007) Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115:584-592
41. Linden W, Gerin W, Davidson K (2003) Cardiovascular reactivity: status quo and a research agenda for the new millennium. Psychosom Med 65:5-8
42. Redwine LS, Wirtz PH, Hong S et al (2009) Potential shift from adaptive immune activity to nonspecific in flammatory activation associated with higher depression symptoms in chronic heart failure patients. J Card Fail 15:607-615
43. Redwine LS, Wirtz PH, Hong S et al (2010) Depression as a potential modulator of betaadrenergic-associated leukocyte mobilization in heart failure patients. J Am Coll Cardiol 56: 1720-1727
44. Bot A, Smith KA, von Herrath M (2004) Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology. DNA Cell Biol 23:341-350
45. Elenkov IJ (2004) Glucocorticoids and the Th1/ Th2 balance. Ann N Y Acad Sci 1024:138-146
46. Fairweather D, Frisancho-Kiss S, Yusung SA et al (2004) Interferon-g protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-b 1, Interleukin-1 b, and Interleukin-4 in the Heart. Am J Pathol 165:1883-1894
47. Afanasyeva M, Georgakopoulos D, Belardi DF et al (2005) Impaired up-regulation of CD25 on CD4+ T cells in IFN-g knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci USA 102: 180-185
48. Redwine LS, Mills PJ, Hong S et al (2007) Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med 69:23-29